Dr. Minh Trương Công

Medical Oncologist | Oncology Researcher

Medical Oncologist specializing in thoracic and urogenital cancer treatments at K National Hospital. Dedicated to improving patient outcomes through evidence-based medicine and clinical research.

Get in TouchView Publications

Education

Resident doctor of Oncology

Hanoi Medical University

September 2018 – August 2021

  • Master's degree included in residency program
  • Achieved a GPA of 8.7/10

General Practitioner

Hanoi Medical University

August 2012 – August 2018

  • GPA: 8.1/10

Employment

Medical Oncologist

K National Hospital, Hanoi

September 2021 – Present

  • Specializing in Medical Oncology 2 department
  • Focus on thoracic and urogenital cancer treatments

Publications

2025

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

Ther Adv Med Oncol

Co-author

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring epidermal growth factor receptor-G719X mutation treated by afatinib: real-world data from a multicenter study in Vietnam

Ther Adv Respir Dis

Co-author

Real-World Evidence for First-Line afatinib in Advanced Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations Other than G719X/L861Q/S768I

Cancer Control

Co-author

Real-World Effectiveness and Safety of Ribociclib Plus Aromatase Inhibitors in Patients with HR+/HER2- Metastatic Breast Cancer: A Multicenter Experience from Vietnam

Asian Pac J Cancer Prev

Co-author

2024

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

Ther Adv Med Oncol

Co-author

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam

BMC Cancer

Co-author

2021

Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam

Asian Pac J Cancer Prev

Co-author

Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam

Asian Pac J Cancer Prev

Corresponding author

Achievements

2026-2027

International Clinical Research Scholars (ICRS) Program Award

ASCO Asia Pacific Regional Council

  • Awarded by ASCO Asia Pacific Regional Council with support from ASCO Conquer Cancer Mission Endowment
  • This award recognizes professional achievements and potential as a leader of oncology research
  • Participating in a 1-year program that provides training for investigators and mentorship from research experts
November 2023

TLCS Research Investigator Award

ASPIRE workshop, Taipei

  • Recognized for presentation: 'A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam'

Contact

📍

Address

K National Hospital, 30 Cau Buou, Thanh Tri District, Hanoi

📞
✉️
🎂

Date of Birth

29/11/1994

🌍

Nationality

Vietnam

🗣️

Languages

EnglishVietnamese